We are live on
!
Find out more
Lexicon Pharmaceuticals
LXRX
LXRX
103 hedge funds and large institutions have $813M invested in Lexicon Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 31 increasing their positions, 32 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 32
4% less capital invested
Capital invested by funds: $846M → $813M (-$33.2M)
6% less funds holding
Funds holding: 109 → 103 (-6)
43% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 14
Holders
103
Holders Change
-6
Holders Change %
-5.5%
% of All Funds
2.98%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
8
Increased
31
Reduced
32
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.28M |
| 2 |
UBS AM
Chicago,
Illinois
|
+$2.1M |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.52M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.11M |
| 5 |
Royal London Asset Management
United Kingdom
|
+$953K |
Top Sellers
| 1 |
JG
Jefferies Group
New York
|
-$3.81M |
| 2 |
GF
Gabelli Funds
Rye,
New York
|
-$2.51M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.8M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$1.77M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$554K |
